Media type: E-Article Title: Commentary on A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines Contributor: Hausauer, Amelia K. imprint: Ovid Technologies (Wolters Kluwer Health), 2021 Published in: Dermatologic Surgery Language: English DOI: 10.1097/dss.0000000000002563 ISSN: 1076-0512; 1524-4725 Keywords: Dermatology ; General Medicine ; Surgery Origination: Footnote: